Cristina E.
- Country
- Spain
- Department
- Hematology
Research Overview
- Safety Evaluation of CC-93269 in Patients with Relapsed and Refractory Multiple Myeloma
- Efficacy and Safety of Etentamig and Daratumumab Versus Daratumumab and Combination Therapy in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma
- A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2
Data & Insights
Has run more than one trial at 180 of 336 partner sites.
Specializations
Hematologic malignancies and cellular therapies
Clinical research activity in hematology centers on acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, multiple myeloma, and lymphomas, with additional involvement in CAR T-cell therapy, gene-modified T cells, and hematopoietic stem cell transplantation.
- Acute myeloid leukemia
- Multiple myeloma
- Diffuse large B-cell lymphoma
- Myelodysplastic syndromes
- Cellular immunotherapy
Her trial portfolio also includes graft-versus-host disease, immune thrombocytopenia, and other blood and lymphatic disorders linked to advanced treatment strategies in malignant and post-transplant settings.
Breast cancer and other solid tumors
Her oncologic research includes breast cancer across early and metastatic disease, with strong activity in HER2-positive, HER2-negative, hormone receptor-positive, and triple-negative breast cancer, as well as colorectal cancer, lung cancer, and gastrointestinal malignancies.
- Breast cancer
- Non-small cell lung cancer
- Colorectal cancer
- Gastroesophageal adenocarcinoma
- Pancreatic cancer
She is also involved in studies of melanoma, urothelial carcinoma, ovarian cancer, and sarcomas, reflecting a broad focus on advanced solid-tumor care and targeted oncology.
Liver disease and gastroenterology
Her research landscape includes chronic liver disease, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, with attention to both inflammatory and fibrotic liver conditions.
- Primary biliary cholangitis
- Non-alcoholic steatohepatitis
- Hepatocellular carcinoma
- Cholestatic pruritus
- Advanced chronic liver disease
Additional activity extends to cholangiocarcinoma, gastroesophageal junction cancer, and pancreatic ductal adenocarcinoma, alongside symptom-focused liver research such as fatigue and pruritus.
Autoimmune, inflammatory, and immune-mediated disorders
Her clinical trial involvement includes systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, and idiopathic inflammatory myopathies, with further work in atopic dermatitis, hidradenitis suppurativa, and psoriasis.
- Systemic lupus erythematosus
- Lupus nephritis
- Psoriatic arthritis
- Atopic dermatitis
- Hidradenitis suppurativa
She also participates in research on immune thrombocytopenia, autoimmune hemolytic anemia, and thrombotic thrombocytopenic purpura, supporting therapeutic development in immune dysregulation and inflammatory disease.
Cardiometabolic, respiratory, and renal disease
Her broader clinical portfolio covers heart failure, atherosclerotic cardiovascular disease, myocardial infarction, stroke prevention, obesity, and type 2 diabetes, alongside chronic kidney disease and renal impairment.
- Heart failure
- Atherosclerotic cardiovascular disease
- Chronic kidney disease
- Obesity
- Type 2 diabetes
She is additionally involved in studies of asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and systemic sclerosis-associated interstitial lung disease, indicating interest in complex multisystem disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.